LACK OF ASSOCIATION BETWEEN IL28B VARIANTS AND HBSAG CLEARANCE AFTER INTERFERON TREATMENT

被引：8
|
作者：
Mangia, A. [1 ]
Santoro, R. [1 ]
Mottola, L. [1 ]
Fasano, M. [2 ]
Minerva, N. [3 ]
Bacca, D. [5 ]
Piazzolla, V. [1 ]
Carretta, V. [4 ]
Termite, A. [6 ]
Agostinacchio, E. [7 ]
Facciorusso, D. [1 ]
Petruzzellis, D. [1 ]
Santantonio, T. [8 ]
机构：
[1] IRCCS Casa Sollievo della Sofferenza Hosp, Liver Unit, San Giovanni Rotondo, Italy
[2] Univ Bari, Clin Infect Dis, Bari, Italy
[3] Hosp Canosa, Canosa, Italy
[4] Hosp Venosa, Venosa, Italy
[5] Hosp Casarano, Casarano, Italy
[6] Motala Hosp, Liver Unit, Mottola, Italy
[7] Clin Santa Rita, Bari, Italy
[8] Univ Foggia, Clin Infect Dis, Foggia, Italy
来源：
JOURNAL OF HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
10.1016/S0168-8278(11)61333-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1331
引用
收藏
页码：S525 / S525
页数：1
相关论文
共 50 条
  • [31] IL28B AND ITPA GENE VARIANTS CORRELATE WITH TREATMENT EFFICACY IN PEGYLATED-INTERFERON PLUS RIBAVIRIN THERAPY FOR CHRONIC HEPATITIS C
    Matsuura, Kentaro
    Tanaka, Yasuhito
    Nishida, Nao
    Sugiyama, Masaya
    Watanabe, Tsunamasa
    Sugauchi, Fuminaka
    Kurosaki, Masayuki
    Izumi, Namiki
    Sakamoto, Naoya
    Enomoto, Nobuyuki
    Yatsuhashi, Hiroshi
    Nishiguchi, Shuhei
    Hino, Keisuke
    Kaneko, Shuichi
    Nojiri, Shunsuke
    Joh, Takashi
    Tokunaga, Katsushi
    Mizokami, Masashi
    HEPATOLOGY, 2011, 54 : 830A - 830A
  • [32] Association of IL28B Variants With Response to Pegylated-Interferon Alpha Plus Ribavirin Combination Therapy Reveals Intersubgenotypic Differences Between Genotypes 2a and 2b
    Sakamoto, Naoya
    Nakagawa, Mina
    Tanaka, Yasuhito
    Sekine-Osajima, Yuko
    Ueyama, Mayumi
    Kurosaki, Masayuki
    Nishida, Nao
    Tamori, Akihiro
    Yuki, Nishimura-Sakurai
    Itsui, Yasuhiro
    Azuma, Seishin
    Kakinuma, Sei
    Hige, Shuhei
    Itoh, Yoshito
    Tanaka, Eiji
    Hiasa, Yoichi
    Izumi, Namiki
    Tokunaga, Katsushi
    Mizokami, Masashi
    Watanabe, Mamoru
    JOURNAL OF MEDICAL VIROLOGY, 2011, 83 (05) : 871 - 878
  • [33] Reply to "Association between IL28B polymorphism and treatment response in patients with genotype 4 chronic hepatitis C"
    Estrabaud, Emilie
    Lada, Olivier
    Asselah, Tarik
    JOURNAL OF HEPATOLOGY, 2012, 57 (03) : 706 - 707
  • [34] IL28B genotyping and treatment of HCV infected subjects
    Novotny, Dalibor
    Roubalova, Lucie
    Aiglova, Kvetoslava
    Bednarikova, Jana
    Bartkova, Margita
    ASIAN BIOMEDICINE, 2014, 8 (04) : 445 - 452
  • [35] Genetics of IL28B and HCV—response to infection and treatment
    C. Nelson Hayes
    Michio Imamura
    Hiroshi Aikata
    Kazuaki Chayama
    Nature Reviews Gastroenterology & Hepatology, 2012, 9 : 406 - 417
  • [36] IL28B gene variants and glucose metabolism in Type 2 Diabetes
    Moran-Auth, Y.
    Penna-Martinez, M.
    Perner, D.
    Susser, S.
    Wicker, S.
    Zeuzem, S.
    Sarrazin, C.
    Badenhoop, K.
    HUMAN IMMUNOLOGY, 2016, 77 (12) : 1280 - 1283
  • [37] GENETIC VARIANTS IN IL28B PROMOTER INFLUENCE THE GENE EXPRESSION LEVELS
    Sugiyama, Masaya
    Tanaka, Yasuhito
    Nakanishi, Makoto
    Mizokami, Masashi
    HEPATOLOGY, 2010, 52 (04) : 762A - 762A
  • [38] IL28B Polymorphism Is Associated with Both Side Effects and Clearance of Hepatitis C During Interferon-Alpha Therapy
    Lotrich, Francis E.
    Loftis, Jennifer M.
    Ferrell, Robert E.
    Rabinovitz, Mordechai
    Hauser, Peter
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2011, 31 (03): : 331 - 336
  • [39] Simultaneous Genotyping of rs12979860 and rs8099917 Variants Near the IL28B Locus Associated with HCV Clearance and Treatment Response
    Melis, Roberta
    Fauron, Christiane
    McMillin, Gwendolyn
    Lyon, Elaine
    Shirts, Brian
    Hubley, Lindsey M.
    Slev, Patricia R.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2011, 13 (04): : 446 - 451
  • [40] Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C
    Staettermayer, A. F.
    Strassl, R.
    Maieron, A.
    Rutter, K.
    Stauber, R.
    Strasser, M.
    Beinhardt, S.
    Datz, C.
    Scherzer, T. -M.
    Steindl-Munda, P.
    Gschwantler, M.
    Trauner, M.
    Hofer, H.
    Ferenci, P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (01) : 104 - 111
12345